Newsom explained in his veto letter that the bill would prohibit retail establishments from selling, transferring, or providing, dietary supplements for weight loss or over-the-counter diet pills to anyone under 18 years of age without a prescription, or valid ID prior to purchasing. AB-1341 also would require the California Department of Public Health (CDPH) to establish a list of dietary supplements that would be subject to such restrictions.
Outlining his reasons for vetoing the bill, Newsomsaid: "I commend the work of the author as this bill raises an important public health issue related to the safety of diet or weight loss pills that can result in injury. However, dietary supplements for weight loss are not considered drugs and, therefore, this measure would require CDPH to evaluate every individual weight loss and dietary supplement product for safety, which is beyond the scope of the department's capabilities."
As future steps, Newsom:
- Called for CDPH to form a workgroup including academic and medical experts to develop public policy recommendations on the best way to educate the public health on the topic of supplements for weight loss.
- Noted that CDPH "is prepared to work with the legislature next session to address sales age limits and other potential legislative actions to address the responsible sale of dietary supplements for weight loss and over-the-counter diet pills that do not require the state to undertake lengthy and costly pharmacologica l studies on the many supplements on the market today."
Industry Responds to News of the Veto
The Natural Products Association (NPA), which has been working to fight the bill and led a grassroots campaign to mobilize industry members, said the veto was "a big win for American consumers, free enterprise, and thousands of small and large businesses in California." NPA pointed to the larger impact the bill would have had, explaining that it would have "required brick and mortar retailers to post warning signs at purchase counters saying that dietary supplements are known to cause serious adverse events, including stroke, organ failure, and even death despite no scientific evidence supporting the claim. The bill had no such similar warning requirements for online sales."NPA took several actions to fight AB-1314
Actions from NPA include:- Sending a letter to Newsom asking that the bill be vetoed.
- Sending letter to the CDPH director urging him to recognize the importance of dietary supplementation and the scientific evidence from the FDA showing there is no correlation between dietary supplement use and eating disorders.
- Testifying against the bill.
AHPA & CRN engaged with bill's sponsor
Also sharing news of the veto, the American Herbal Products Association (AHPA) reported that, over the last two years,they trade group "has worked closely and directly with Assemblymember Cristina Garcia, the bill’s sponsor, to present the interests of consumers and the responsible sports nutrition industry."The Council for Responsible Nutrition (CRN) said that while CRN opposed the initial version of AB-1341, the group "engaged with Assemblymember Garcia to reach an amended version that required CDPH to evaluate products individually, rather than imposing a categorical restriction on dietary supplements." CRN noted that the amended version of the bill "removed liability from retail clerks and eliminated the restricted access to affected products as originally included in the legislation." When the bill passed the Senate with those changes, CRN removed its opposition and took a neutral position.
Julia Gustafson, CRN Vice President, Government Relations, said, “CRN had multiple conversations and a good working relationship with bill author Assemblymember Cristina Garcia and her staff. We appreciate her willingness to include practical measures in the final version of her legislation that limited its scope and removed behind-the-counter restrictions...We expect this bill or similar proposals to be reconsidered during the next legislative session. CRN stands ready to work with the lawmakers to ensure this legislation is reintroduced in a way that responsibly balances consumer safety with public access to dietary supplements.”
